Home | Sitemap | Submit Content | Contact Us   
imageHome : Latest News : Neurosearch Q3 pretax loss widens on higher R&D costs; group seeks ...

Neurosearch Q3 pretax loss widens on higher R&D costs; group seeks ...

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service112 times read : Adjust font size: Decrease font Enlarge font
image

CNBC - COPENHAGEN (Thomson Financial) - Danish pharmaceutical company Neurosearch AS posted a third quarter pretax loss of 74 mln dkr, versus a 34 mln dkr loss a year earlier, on the back of higher costs for research and development. Third quarter sales ...

Read this article...



Post your comment comment Comments (0 posted)

copyright